Twitter Analysis of #OpenAPS DIY Artificial Pancreas Technology Use Suggests Improved A1C and Quality of Life

Michelle L. Litchman, Dana Lewis, Lesly Kelly, Perry M. Gee

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Background: Patient-driven innovation in diabetes management has resulted in a group of people with type 1 diabetes who choose to build and share knowledge around a do-it-yourself (DIY) open source artificial pancreas systems (OpenAPS). The purpose of this study was to examine Twitter data to understand how patients, caregivers, and care partners perceive OpenAPS, the personal and emotional ramifications of using OpenAPS, and the influence of OpenAPS on daily life. Methods: Qualitative netnography was used to analyze #OpenAPS on Twitter over a two-year period. Results: There were 328 patients, caregivers, and care partners who generated 3347 tweets. One overarching theme, OpenAPS changes lives, and five subthemes emerged from the data: (1) OpenAPS use suggests self-reported A1C and glucose variability improvement, (2) OpenAPS improves sense of diabetes burden and quality of life, (3) OpenAPS is perceived as safe, (4) patient/caregiver–provider interaction related to OpenAPS, and (5) technology adaptation for user needs. Conclusions: As users of a patient-driven technology, OpenAPS users are self-reporting improved A1C, day-to-day glucose levels, and quality of life. Safety features important to individuals with diabetes are perceived to be embedded into OpenAPS technology. Twitter analysis provides insight on a patient population driving an innovative solution to improve their quality of diabetes care.

Original languageEnglish (US)
Pages (from-to)164-170
Number of pages7
JournalJournal of Diabetes Science and Technology
Volume13
Issue number2
DOIs
StatePublished - Mar 1 2019

Fingerprint

Artificial Pancreas
Medical problems
Quality of Life
Technology
Glucose
Innovation
Caregivers
Patient Care
Quality of Health Care
Type 1 Diabetes Mellitus

Keywords

  • artificial pancreas
  • diabetes
  • OpenAPS
  • patient innovation
  • social media
  • Twitter

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Bioengineering
  • Biomedical Engineering

Cite this

Twitter Analysis of #OpenAPS DIY Artificial Pancreas Technology Use Suggests Improved A1C and Quality of Life. / Litchman, Michelle L.; Lewis, Dana; Kelly, Lesly; Gee, Perry M.

In: Journal of Diabetes Science and Technology, Vol. 13, No. 2, 01.03.2019, p. 164-170.

Research output: Contribution to journalArticle

Litchman, Michelle L. ; Lewis, Dana ; Kelly, Lesly ; Gee, Perry M. / Twitter Analysis of #OpenAPS DIY Artificial Pancreas Technology Use Suggests Improved A1C and Quality of Life. In: Journal of Diabetes Science and Technology. 2019 ; Vol. 13, No. 2. pp. 164-170.
@article{fb7501cc26294b20b741d54a685665a7,
title = "Twitter Analysis of #OpenAPS DIY Artificial Pancreas Technology Use Suggests Improved A1C and Quality of Life",
abstract = "Background: Patient-driven innovation in diabetes management has resulted in a group of people with type 1 diabetes who choose to build and share knowledge around a do-it-yourself (DIY) open source artificial pancreas systems (OpenAPS). The purpose of this study was to examine Twitter data to understand how patients, caregivers, and care partners perceive OpenAPS, the personal and emotional ramifications of using OpenAPS, and the influence of OpenAPS on daily life. Methods: Qualitative netnography was used to analyze #OpenAPS on Twitter over a two-year period. Results: There were 328 patients, caregivers, and care partners who generated 3347 tweets. One overarching theme, OpenAPS changes lives, and five subthemes emerged from the data: (1) OpenAPS use suggests self-reported A1C and glucose variability improvement, (2) OpenAPS improves sense of diabetes burden and quality of life, (3) OpenAPS is perceived as safe, (4) patient/caregiver–provider interaction related to OpenAPS, and (5) technology adaptation for user needs. Conclusions: As users of a patient-driven technology, OpenAPS users are self-reporting improved A1C, day-to-day glucose levels, and quality of life. Safety features important to individuals with diabetes are perceived to be embedded into OpenAPS technology. Twitter analysis provides insight on a patient population driving an innovative solution to improve their quality of diabetes care.",
keywords = "artificial pancreas, diabetes, OpenAPS, patient innovation, social media, Twitter",
author = "Litchman, {Michelle L.} and Dana Lewis and Lesly Kelly and Gee, {Perry M.}",
year = "2019",
month = "3",
day = "1",
doi = "10.1177/1932296818795705",
language = "English (US)",
volume = "13",
pages = "164--170",
journal = "Journal of diabetes science and technology",
issn = "1932-2968",
publisher = "Diabetes Technology Society",
number = "2",

}

TY - JOUR

T1 - Twitter Analysis of #OpenAPS DIY Artificial Pancreas Technology Use Suggests Improved A1C and Quality of Life

AU - Litchman, Michelle L.

AU - Lewis, Dana

AU - Kelly, Lesly

AU - Gee, Perry M.

PY - 2019/3/1

Y1 - 2019/3/1

N2 - Background: Patient-driven innovation in diabetes management has resulted in a group of people with type 1 diabetes who choose to build and share knowledge around a do-it-yourself (DIY) open source artificial pancreas systems (OpenAPS). The purpose of this study was to examine Twitter data to understand how patients, caregivers, and care partners perceive OpenAPS, the personal and emotional ramifications of using OpenAPS, and the influence of OpenAPS on daily life. Methods: Qualitative netnography was used to analyze #OpenAPS on Twitter over a two-year period. Results: There were 328 patients, caregivers, and care partners who generated 3347 tweets. One overarching theme, OpenAPS changes lives, and five subthemes emerged from the data: (1) OpenAPS use suggests self-reported A1C and glucose variability improvement, (2) OpenAPS improves sense of diabetes burden and quality of life, (3) OpenAPS is perceived as safe, (4) patient/caregiver–provider interaction related to OpenAPS, and (5) technology adaptation for user needs. Conclusions: As users of a patient-driven technology, OpenAPS users are self-reporting improved A1C, day-to-day glucose levels, and quality of life. Safety features important to individuals with diabetes are perceived to be embedded into OpenAPS technology. Twitter analysis provides insight on a patient population driving an innovative solution to improve their quality of diabetes care.

AB - Background: Patient-driven innovation in diabetes management has resulted in a group of people with type 1 diabetes who choose to build and share knowledge around a do-it-yourself (DIY) open source artificial pancreas systems (OpenAPS). The purpose of this study was to examine Twitter data to understand how patients, caregivers, and care partners perceive OpenAPS, the personal and emotional ramifications of using OpenAPS, and the influence of OpenAPS on daily life. Methods: Qualitative netnography was used to analyze #OpenAPS on Twitter over a two-year period. Results: There were 328 patients, caregivers, and care partners who generated 3347 tweets. One overarching theme, OpenAPS changes lives, and five subthemes emerged from the data: (1) OpenAPS use suggests self-reported A1C and glucose variability improvement, (2) OpenAPS improves sense of diabetes burden and quality of life, (3) OpenAPS is perceived as safe, (4) patient/caregiver–provider interaction related to OpenAPS, and (5) technology adaptation for user needs. Conclusions: As users of a patient-driven technology, OpenAPS users are self-reporting improved A1C, day-to-day glucose levels, and quality of life. Safety features important to individuals with diabetes are perceived to be embedded into OpenAPS technology. Twitter analysis provides insight on a patient population driving an innovative solution to improve their quality of diabetes care.

KW - artificial pancreas

KW - diabetes

KW - OpenAPS

KW - patient innovation

KW - social media

KW - Twitter

UR - http://www.scopus.com/inward/record.url?scp=85059701624&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85059701624&partnerID=8YFLogxK

U2 - 10.1177/1932296818795705

DO - 10.1177/1932296818795705

M3 - Article

C2 - 30198751

AN - SCOPUS:85059701624

VL - 13

SP - 164

EP - 170

JO - Journal of diabetes science and technology

JF - Journal of diabetes science and technology

SN - 1932-2968

IS - 2

ER -